ArticleJAMA network open2020

Financial Implications of Avapritinib for Treatment of Unresectable Gastrointestinal Stromal Tumors in Patients With a PDGFRA Exon 18 Variant or After 3 Previous Therapies in a Hypothetical US Health Plan.

David Proudman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.